Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02706392
Title Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Fred Hutchinson Cancer Research Center
Indications

triple-receptor negative breast cancer

chronic lymphocytic leukemia

acute lymphoblastic leukemia

lung non-small cell carcinoma

mantle cell lymphoma

Therapies

Cyclophosphamide + Fludarabine + ROR1 CAR-T cells

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.